Zusammenfassung
Störungen des Lipid- und Lipoproteinstoffwechsels bei chronisch niereninsuffizienten Patienten werden seit Jahren beschrieben. Ihre klinische Bedeutung, besonders im Hinblick auf ein erhöhtes Atheroskleroserisiko bleibt bis heute umstritten. Während Lindner et al. [2] auf hohe kardiovaskuläre Risiken bei Dialysepatienten hinweisen, wird dieser Zusammenhang in neueren Untersuchungen wie von Nicholls [3] in Frage gestellt. Schon 1980 haben wir darauf hingewiesen, daß bei CAPD-Patienten möglicherweise eine Tendenz zu erhöhten Cholesterinwerten besteht [1]. Nachdem diese Beobachtung von verschiedenen Seiten bestätigt wurde, sahen wir uns veranlaßt, Lipoproteinmessungen vergleichend bei Patienten durchzuführen, die mit Hämodialyse (HD), Hämofiltration (HF), intermittierender Peritonealdialyse (IPD) und CAPD behandelt wurden. Eine solche Gegenüberstellung erschien uns um so reizvoller, als die beiden PD-Verfahren vom Prinzip her mit einer Glukosebelastung verbunden sind, während HD und HF zu einer negativen Glukosebilanz führen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Armstrong VW, Fuchs C, Scheler F (1980) Biochemical studies on patients undergoing continous ambulatory peritoneal dialysis. Klin Wochenschr 58: 1065
Lindner A, Charra B, Sherrard DJ, Scribner BH (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697
Nicholls AJ, Cumming MA, Catto GRD, Edward N, Engeset J (1981) Lipid relationships in dialysis and renal transplant patients. Q J Med 198: 149
Wieland H, Seidel D (1978) Fortschritte in der Analytik des Lipoproteinmusters. Inn Med 5: 290
Wieland H, Seidel D, Wiegand V, Kreuzer H (1980) Serum lipoproteins and coronary artery disease ( CAD ). Atherosclerosis 36: 269
Lindner A, Charra B, Sherrard DJ, et al. (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697–701
Heuck CC, Ritz E (9180) Hyperlipo- proteinemia in renal insufficiency. Nephron 25: 1–7
Bagdade J, Casaretto A, Albers J (1976) Effects of chronic uremia, hemodialysis and renal transplantation on plasma lipids and lipoproteins in man. J Lab Clin Med 87: 37–48
Mordasini R, Frey F, Flury W, Klose G, Greten H (1977) Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med 297: 1362–1366
Hamilton RC, Williams MC, Fielding CJ, Havel RJ (1976) Descoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. J Clin Invest 58: 667–680
Green PHR, Tall AR, Glickman RM (1978) Rat intestine secretes high density lipoprotein. J Clin Invest 61: 528–534
Guarneri GG, Moracchiello M, Campanacci L, Ursini F, Ferri L, Valente M, Gregolin C (1978) Lecithin-cholesterol acyltransferase ( LCAT) activity in chronic uremia. Kidney Int 13: 26–30
Stokke KT, Norum KR (1971) Determination of lecithin: cholesterol acyltransferase in human blood plasma. Scand J Clin Lab Invest 27: 21–27
Burke JF Jr, Francos GC, Moore LL, Yon Cho Sang, Lasker N (1978) Accelerated atherosclerosis in chronic dialysis patients another look. Nephron 21: 181–185
Chan MK, Varghese Z, Baillod RA, Morhead JF (1980) Atherosclerosis in dialysis and renal-transplant patients. Lancet 1: 591–592
Combined report on regular dialysis and transplantation in Europe IX (1978) Proc Eur Dial Transplant Assoc 16: 4–75
Dabels J, Rinke E (1976) Zur klinischen Bedeutung des Risikofaktors Hyperlipoproteinämie. Ber Ges Inn Med 10: 194–196
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observation. J Am Statut Ass 53: 457–481
Lazarus M, Lowrie EG, Hampers CL, Merril JP (1975) Cardiovascular disease in uremic patients on hemodialysis. Kidney Int [Suppl] 2: 167–175
Lindner A, Charra B, Sherrard DJ, Scribner BH (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697–701
Meema HE, Oreopoulos DG, de Veber GA (1976) Arterial calcifications in severe chronic renal disease and their relationship to dialysis treatment, renal transplant, and parathyreodectomy. Radiology 121: 315–321
Nicholls AJ, Catto GRD, Edward N, Engeset J, Macleod M (1980) Accelerated atherosclerosis in long-term dialysis and renal-transplant patients: fact or fiction. Lancet 1: 276–278
Schnyder PA, Gamsu G, Klein DL, Savoca CJ (1979) Accelerated atherosclerosis during maintenance hemodialysis: Detection from chest radiographs. Invest Radio! 14: 405–409
Spencer ES (1980) Atherosclerosis in dialysis and renal-transplant patients. Lancet 1: 591
Bartlett GR (1958) Organization of red cell glycolytic enzymes; cell coat phosphorus transfer. Ann NY Acad Sci 75: 110–113
Cole CH (1973) Decreased ouabain-sensitive adenosine triphosphatase activity in the erythrocyte membrane of patients with chronic renal disease. Clin Sci Mol Med 45: 775–784
Francavilla A, Albano O, Mastrangelo F, Coratelli P, Palasciano G, Amerio A (1972) Studio sull’ATPase Na+-K+ dipendente negli eritrociti di pazienti con insufficienza renale acuta e cronica. Minerva Nefrol 12: 85–91
Garrahan PJ, Glynn IM (1967) The stoicheiometry of the sodium pump. J Physiol (Lond) 192: 217–235
Hanahan DJ, Ekholm J (1972) Changes in erythrocyte membranes during preparation, as expressed by ATPase activity. Biochim Biophys Acta 255: 413–419
Hanahan DJ, Ekholm J, Hildenbrandt G (1973) Biochemical variability of human erythrocyte membrane preparations, as demonstrated by Na-K-Mg and calcium adenosine triphosphatase activities. Biochemistry 12: 1374–1387
Kramer HJ, Gospodinov D, Krück F (1976) Functional and metabolic studies on red blood cell sodium transport in chronic uremia. Nephron 16: 344–358
Schrier SL, Godin D, Gould RG, Swyryd B, Junga I, Seeger M (1971) Characterization of microvesicles produced by shearing of human erythrocyte membranes. Biochim Biophys Acta 233: 26–36
Walter U (1981) Red blood cell sodium and potassium after hydrochlorothiazide. Clin Pharmacol Ther 30: 373–377
Walter U (1981) Inhibition of molybdenum blue formation by ATP. Experientia 37: 1263–1265
Walter U (1981) Effect of ouabain and furosemide on erythrocyte sodium and phosphate transport. Clin Pharmacol Ther 30: 709–717
Walter U, Distler A (1982) Abnormal sodium efflux in erythrocytes of patients with essential hypertension. Hypertension 4: 205–210
Whittam R (1962) The asymmetrical stimulation of a membrane adenosine triphosphatase in relation to active cation transport. Biochem J 84: 110–118
Whittam R, Ager ME (1965) The connexion between active cation transport and metabolism in erythrocytes. Biochem J 97: 214–227
Blagg CR (1974) Visual and vascular problems in dialyzed diabetic patients. Kidney Int [Suppl 1] 6: 27
Flynn CT, Nanson JA (1979) Intraperitoneal insulin with CAPD an artificial pancreas. Trans Am Soc Artif Intern Organs 25: 114–117
Goetz FC, Kjellstrand CM (1979) The treatment of diabetic kidney disease. Diabetologia 17: 267–281
Jacobs C, Broyer M, Brunner FP et al. (1980) Combined report on regular dialysis and transplantation in Europe, XI, 1980. Proc Eur Dial Transplant Assoc 18: 4–58
Katirtzoglou A, Izatt S, Oreopoulos DG et al. (1980) Chronic peritoneal dialysis in diabetics with end-stage renal failure. In: Friedman EA, L’Esperance FA Jr (eds) Diabetic renal-retinal syndrome. Grune & Stratton, New York London, pp 317–331
Najarian JS, Sutherland DER, Simmons RL et al. (1979) Ten years experience with renal transplantation in juvenile onset diabetics. Ann Surg 190: 487–500
Rassissieh SD, Yen MC, Lazarus JM, Lowrie EG, Goldstein HH, Takacs FS, Hampers CL, Merrill JP (1974) Hemodialysis-related problems in patients with diabetes mellitus. Kidney Int [Suppl 1] 6: 100
Battistella PA, Angelini C, Vergani L, Bertoli M, Lorenzi S (1978) Carnitine deficiency induced during haemodialysis. Lancet 1: 939
Bizzi A, Mingardi G, Codegoni AM, Mecca G, Garattini S (1978) Accelerated recovery of postdialysis plasma carnitine fall by oral carnitine. Biomedicine 29: 183–184
Böhmer T, Ryding A, Solberg HE (1974) Carnitine levels in human serum in health and disease. Clin Chim Acta 57: 55–61
Böhmer T, Bergrem H, Eiklid K (1978) Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1: 126–127
Carter AL, Frenkel R (1979) The role of the kidney in the biosynthesis of carnitine in the rat. J Biol Chem 254: 10670–10674
Cederblad G, Lindstedt S (1972) A method for the determination of carnitine in the picomole range. Clin Chim Acta 37: 235–243
McGarry JD, Foster DW (1977) An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res 17: 277–281
Mitchell ME (1978a) Carnitine metabolism in human subjects. I Normal metabolism. Am J Clin Nutr 31: 239–306
Mitchell ME (1978b) Carnitine metabolism in human subjects. III Metabolism in disease. Am J Clin Nutr 31: 645–659
Rieger J, Kramer P (1977) Prinzip und Technik der Hämofiltration. In: Scheler F, Henning HV (Hrsg) Hämofiltration. Dustri-Verlag Dr. Karl Feistle, München-Deisenhofen, S 7–15
Antoniou LD, Shalhoub RI, Sudhakar T, Smith JC (1977) Reversal of uraemic impotence by zinc. Lancet 2: 895
Atkin-Thor E, Goddard BW, O’Nion J, Stephen RL, Kolff WJ (1978) Hypogeusia and zinc depletion in chronic dialysis patients. Am J Clin Nutr 31: 1948
Avram MM, Feinfeld DA, Huatuco AH (1978) Search for the uremic toxin: decreased motor-nerve-conduction velocity and elevated parathyroid hormone in uremia. N Engl J Med 298: 1000
Beckmann H, Ossenkop C, Quellhorst E (1977) Changes in peripheral nerve function with long-term hemofiltration treatment. J Dial 1: 585
Brown JC, Stanley E (1976) Improvement in peripheral nerve function immediately after hemodialysis. Acta Neurol Belg 76: 320
Burge JC, Park HS, Whitlock CP, Schemmel RA (1979) Taste acuity in patients undergoing long-term hemodialysis. Kidney Int 15: 49
Codish SD, Cress RH (1971) Motor and sensory nerve conduction in uremic patients undergoing repeated dialysis. Arch Phys Med Rehabil 52: 260
Condon CJ, Freeman RM (1970) Zinc metabolism in renal failure. Ann Intern Med 73: 531
Cornelis R, Mees L, Ringoir S, Hoste J (1979) Serum and red blood cell Zn, Se, Cs and Rb in dialysis patients. Mineral Elektrolyte Metab 2: 88
Cuncliffe WJ (1979) Unacceptable side-effects of oral zinc sulphate in the treatment of acne vulgaris. Br J Dermatol 101: 363
Dyck PJ, Johnson WJ, Lambert EH, Bushek W, Pollock M (1975) Dectection and evaluation of uremic peripheral neuropathy in patients on hemodialysis. Kidney Int 7S2: 201
Dyck PJ, Johnson WJ, Nelson RA, Lambert EH, O’Brien PC (1975) Uremic neuropathy. III. Controlled study of restricted protein and fluid diet and infrequent hemodialysis versus conventional hemodialysis treatment. Mayo Clin Proc 50: 642
Fornari AJ, Avram MM (1978) Altered taste perception in uremia. Trans Am Soc Artif Intern Organs 24: 385
Fosmire GJ, Al-Ubaidi YY, Sandstead HH (1975) Some effects of postnatal zinc deficiency on developing rat brain. Pediatr Res 9: 89
Hegstrom RM, Murray JS, Pendras JP, Burnell JM, Scribner BH (1962) Two years’s experience with periodic hemodialysis in the treatment of chronic uremia. Trans Am Soc Artif Intern Organs 8: 266
Henkin RJ, Gill JR, Bartter FC (1963) Studies on thresholds in normal man and patients with adrenal cortical insufficiency: The effect of adrenocorticosteroids. J Clin Invest 42: 727
Hurley HS, Shrader RE (1972) Congenital malformation of the nervous system in zinc-deficient rats. Int Rev Neurobiol [Suppl] 1: 7
Kotz L, Kaiser G, Tschöpel P, Tölg G (1972) Aufschluß biologischer Matrices für die Bestimmung sehr niedriger Spurenelementgehalte bei begrenzter Einwaage mit Salpetersäure unter Druck in einem Teflongefäß. Z Anal Chem 260: 207
Krivan V, Geiger H (1981) Bestimmung von Fe, Co, Cu, Zn, Se, Rb and Cs in NBS-Ochsenleber, Blutplasma und Erythrozyten durch INAA und AAS. Fesenius Z Anal Chem 305: 399
Lasker N, Harvey A, Baker H (1963) Vitamin levels in hemodialysis and intermittent peritoneal dialysis. Trans Am Soc Artif Intern Organs 9: 51
Ludin HP (1976) Praktische Elektromyographie. Enke, Stuttgart
Mahajan SK, Gardiner WH, Abbasi AA, Briggs WA, Prasad AS, McDonald FD (1978) Abnormal plasma and erythrocyte zinc distribution in uremia. Trans Am Soc Artif Intern Organs 24: 50
Mahajan SK, Prasad AS, Lambujon J, Abbasi AA, Briggs WA, McDonald FD (1980) Improvement of uremic hypogeusia by zinc: a double-blind study. Am J Clin Nutr 33: 1517
Mansouri K, Halstead JA, Gombos EA (1970) Zinc, copper, magnesium and calcium in dialyzed and nondialyzed uremic patients. Arch Intern Med 125: 88
McBean LD, Smith JS, Halstead JA (1972) Zinc deficiency in guinea pigs. Proc Soc Exp Biol Med 140: 1207
Nielsen VK (1974) The peripheral nerve function in chronic renal failure. IX. Revocery after renal transplantation: electrophysiological aspects (sensory and motor nerve conduction). Acta Med Scand 195: 171
Rose G, Willden EG (1972) Whole blood, red cell and plasma total and ultrafiltrable zinc levels in normal subjects and patients with chronic renal failure with and without hemodialysis. Br J Urol 44: 281
Sprenger KBG, Bundschu D, Figueroa P, Franz HE (1981) Vergleich von Hämofiltration gegenüber Hämodialyse mit kontrollierter Ultrafiltration in einer ABA-Langzeitstudie. NierenHochdruckkrankh 10: 226
Sprenger KBG, Lewis K, Bundschu D, Spohn B, Schmitz J, Franz HE (1982) Klinische Erfahrung mit der Substitution von Zink bei Dialysepatienten. In: Staib J (Hrsg) Spurenelemente (im Druck)
Parker CW, Stenson WF, Huber MG, Kelly JP (1979) J Immunol 122: 1572
Foegh ML, Winchester JF et al. (1981) Lancet 2: 431
Köppers H, Schnurr E (1980) Verh Dtsch Ges Inn Med 86: 686
Goldstein IM, Malmsten CL et al. (1978) J Exp Med 148: 787
Dunn MJ, Hood VL (1977) Am J Physiol 233: F169
Barin F, Denis F, Chiron JP, Goudeau A, Yvonnet B, Coursaget P (1982) Immune response in neonates to hepatitis-B-vaccine. Lancet 1: 251–253
Buynak EB, Roehm RR, Tytell AA, Bertland AU, Lampson GP, Hilleman MR (1976) Vaccine against human hepatitis-B. JAMA 235: 2833–2834
Gerlich WH, Lüer W (1979) Selective detection of IgM-antibody against core antigen of the hepatitis-B-virus by a modified enzyme immune assay. J Med Virol 4: 227–238
Hilleman MR, Bertland AU, Buynak EB, Lampson GP, McAleer WJ, McLean AA, Roehm RR, Tytell AA (1979) Clinical and laboratory studies of hepatitis-B surface antigen vaccine. Infection 7: 215
Hollinger FB, Adam E, Heiberg D, Melnic JL (1981) Response to hepatitis-B-vaccine in a young adult population (in press)
Krugman S, Giles JP (1973) Viral hepatitis, type B (MS-2 strain). Further observations on natural history and prevention. N Engl J Med 288: 755–760
Krugman S, Giles JP, Hammond J (1970) Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strains. J Infect Dis 122: 432–436
Krugman S, Giles JP, Hammond J (1971) Viral hepatitis, type B (MS-2 strain): studies on active immunization. JAMA 217: 41–45
Maupas P, Barin F, Chiron JP, Coursaget P, Goudeau A (1981) Efficacy of hepatitis-B-vaccine in prevention of early HBS Ag carrier state in children. Lancet 2: 289–292
Szmuness W (1979) Large-seale efficacy trials of hepatitis-B-vaccines in the USA: Baseline data and protocols. J Med Virol 4: 327–340
Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadowsky R, Morrison JM, Kellner A (1980) Hepatitis-B-vaccine. Demonstration of efficacy in a controlled clinical trial in a high risk population in the United States. N Engl J Med 303: 833–841
Zachoval R, Frösner G, Deinhardt F (1981) Impfung gegen Hepatitis-B. Munch Med Wochenschr 40: 1506–1508
Müller GA, Wernet P, Baldwin W, van Es LA (1981) Die Verteilung von HLA-DR-Antigenen auf glomerulären Epithelzellen und peritubulären Kapillarendothelien der menschlichen Niere. Verh Dtsch Ges Inn Med 87: 697–699
Häyry P, von Willebrand E, Anderson LC (1980) Expression of HLA-ABC and -DR locus antigens on human kidney, endothelial, tubular and glomerular cells. Scand J Immunol 11: 303–310
Hart DNJ, Fuggle SV, Williams KA, Fabre JW, Ting A, Morris PJ (1981) Localization of HLA-ABC and DR antigens in human kidney. Transplantation 31: 428–433
Hart DNJ, Fabre JW (1980) Kidney-specific alloantigen system in the rat. J Exp Med 151: 651–666
Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497
Müller C, Schiich K, Pawelec G, Wilms K, Wernet P (1982) Immunohistology of graft-versus-host disease mediated skin lesions and its correlation to a large granular lymphocyte surface phenotype and function. Blut 44: 89–94
Keiser HR, Margolius HS, Brown R, Rhamey R, Foster J (1976) Urinary kallikrein in patients with renovascular hypertension. In: Pisano JJ, Austen KF (eds) Chemistry and biology of the kallikrein-kinin system in health and disease. Fogarty Center Proceedings No. 27. US Government Printing Office, Washington, p 423
Hörl WH, Heidland A (1981) Inactivation of urinary kallikrein by alphas-antitrypsin. Klin Wochenschr 59: 761–763
Jennissen HP, Heilmeyer LMG Jr (1974) An automated assay for phosphorylase kinase. Anal Biochem 57: 118–126
Cohen P (1973) The subunit structure of rabbit skeletal muscle phosphorylase kinase and the molecular basis of its activation reactions. Eur J Biochem 34: 1–14
Becher HJ, Weise HJ, Volkermann U, Schollmeyer P (1980) Enhanced purine nucleotide synthesis in erythrocytes of uremic patients. Klin Wochenschr 58: 1243–1250
Bock HE, Löhr GW, Waller HD (1962) Beitrag zur Pathogenese renaler Anämien. Schweiz Med Wochenschr 92: 1213
Chillar RK, Desforges JF (1974) Red-cell organic phosphates in patients with chronic renal failure on maintenance haemodialysis. Br J Haematol 26: 549–556
Hurt GA, Chanutin A (1964) Organic phosphate compounds of erythrocytes from individuals with uremia. J Lab Clin Med 64: 675–684
Jahrmärker H (1964) Cher den Adeninnucleotidgehalt der Erythrozyten bei Niereninsuffizienz. Klin Wochenschr 42: 123–126
Kramer JH, Gospodinov D, Krück F (1976) Functional and metabolic studies on red blood cell sodium transport in chronic uremia. Nephron 16: 344–358
Lichtman M, Miller DR (1970) Erythrocyte glycolysis 2,3-diphosphoglycerate and adenosine triphosphate concentration in uremic subjects: Relationship to extracellular phosphate concentration. J Lab Clin Med 76: 267–279
Rees SB, Scheitlin WG, Pond JC, McManus TJ, Guild WR, Merrill JP (1957) Effect of dialysis and purine ribosides upon the anemia of uremia. J Clin Invest 36: 923
Schneider W, Jutzler GA (1974) Implications of cyclic adenosine 3’,5’-monophosphate in chronic renal failure. N Engl J Med 291: 155
Schneider W (1978) Zur Pathogenese der urämischen Thrombozytopenie. In: Marx R, Thies HA (Hrsg) Niere, Blutgerinnung and Hämostase. Schattauer, Stuttgart New York, S 227
Wallas CH (1974) Metabolic studies on red cells from patients with chronic renal disease on haemodialysis. Br J Haematol 26: 71–78
Welt LG, Sachs JR, McManus TJ (1964) An ion transport defect in erythrocytes from uremic patients. Trans Assoc Am Physicians 77: 169–181
Brickman AS, Hartenbower DL, Norman WW (1975) Action of 1,25 (OH)2 and 1-alpha-vitamin D3 on magnesium metabolism in man. Clin Res 23: 315A
Hodgkinson A, Marshall DH, Nordin BEC (1979) Vitamin D and magnesium absorption in man. Clin Sci 57: 121–123
Kanis JA, Smith R, Walton RJ, Bartlett M (1977) Effect of 1-alpha-hydroxycholecalciferol on magnesium metabolism in chronic renal failure. Br Med J 1: 211
Levine BS, Brautbar N, Walling MW, Lee DBN, Coburn JW (1980) Effects of vitamin D and diet magnesium on magnesium metabolism. Am J Physiol [Endocrinol Metab 2] 239: 515–523
Rehner G, Daniel H, Aeppli-Schmidt R (1981) In vitro perfusion technique for investigations on the intestinal transport of water soluble substances. J Pharmacol Methods 5: 349–357
Tougard L, Sorensen E, Brochner-Mortensen J, Christensen MS, ROdbro P, Sorensen AWS (1976) Controlled trial of 1-alpha-hydroxycholecalciferol in chronic renal failure. Lancet 1: 1044–1047
Carson CP, Ackerman LU, Maltby JD (1955) Plasma cell myeloma: Clinical, pathologic, and roentgenologic review of 90 cases. Am J Clin Pathol 25: 849
Schubert GE (1970) Morphologie der Nieren beim Plasmozytom. VII. Symp d Ges f Nephrologie, S 215
Fine JD, Rees ED (1977) Renal cytotoxic effect of Bence Jones proteins. Lancet 1: 150
Levi DF, Williams RC, Liustrom FD (1968) Immunofluorescent studies of the myeloma kidney with special reference to light chain disease. Am J Med 44: 922
Preuss HG, Weiss FR, Jammarino RM, Hammack W, Murdaugh HV (1974) Effects of rat kidney slice function in vitro of proteins from the urines of patients with myelomatosis and nephrosis. Clin Sci Mol Med 46: 283
Weise M et al. (1981) ß2-microglobulin and other proteins as parameter for tubular function. Contrib Nephrol 24: 88
Hobler H, Keller M, Weise M (1981) Laser nephelometry of albumin in urine by equivalence-point estimation. Kidney Int 20: 150
Mondorf AW et al. (1978) The effect of aminoglycosides on proximal tubular membranes of the human kidney. Ear J Clin Pharmacol 13
Boesken WH, Boesken S, Mamier A (1979) Myoglobinuria. Curr Probl Clin Biochem 9: 316–324
Boesken WH. Harnuntersuchung bei Nierenkrankheiten (Eiweiß). In: Losse H, Renner E (Hrsg) Klinische Nephrologie 1/136. Thieme, Stuttgart New York
Clyne DH, Pesce AJ, Thompson RE (1979) Nephrotoxicity of Bence Jones proteins in the rat: importance of protein isoelectric point. Kidney Int 16: 345–352
Gutensohn G, Boesken W, Weisshaar D, Hellweg K, Tritschler W, Benauch P, Besenfelder E (1978) Vergleichsuntersuchung mit einem neuen Eiweißtest-streifen. Med Lab (Stuttg) 31: 181–194
Maack Th, Johnson V, Kau ST, Figueiredo J, Sigulem D (1979) Renal filtration, transport, and metabolism of low-molecular weight proteins: A review. Kidney Int 16: 251–270
Boesken WH, Kopf K, Schollmeyer P (1973) Differentiation of proteinuric diseases by disc-electrophoretic molecular weight analysis of urinary proteins. Clin Nephrol 5: 311
Boesken WH (1975) Die tubuläre Proteinurie. Klin Wochenschr 53: 473
Boesken WH (1977) Die SDS-PAA-Elektrophorese der Urinproteine. Eine Methode zur Differentialdiagnose der Nephropathien und zur Analyse extrarenaler Proteinurien. Urologe [B] 17: 140
Boesken WH (1978) Vergleich von Histologie und Urinproteinanalyse bei Nierenerkrankungen. Nieren-und Hochdruckkrankheiten 5: 206
Lison AE, Asscher AW, Davies M, Hopkins M, Fifield R, Elwood PC (1977) Häufigkeit niedermolekularer Proteine im Urin. Verh Dtsch Ges Inn Med 83: 1262
Lison AE, Frommeyer L, Spieker C, Reisch A, Kösters MC (1981) Epidemiologische Untersuchung über die Häufigkeit der bakteriellen Niereninfektion in der Bevölkerung. Forschungsberichte des Landes NRW, Fachgruppe Medizin, Nr. 3007. Westdeutscher Verlag
Lowry OH, Rosebrough N, Farr AL, Randall RJ (1951) Protein measurement with the folinphenol reagent. J Biol Chem 193: 265
Dinarello CA et al. (1974) Colchicine therapy for familial mediterranean fever: a double blind trial. N Engl J Med 291: 934–937
Glenner GG (1980) Amyloid deposits and amyloidosis. N Engl J Med 302: 1283–1292, 1333–1343
Madias N, Metaxas P (1981) Familial mediterranean fever and amyloidosis. Nephrology forum. Kidney Int 20: 676–685
Ravid M et al. (1977) Prolonged colchicine treatment in four patients with amyloidosis. Ann Intern Med 87: 568–570
Shirahama T, Cohen AS (1974) Blockage of amyloid induction by colchicine in an animal model. J Exp Med 140: 1102–1107
Zemer D et al. (1974) A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med 291: 932–934
Zemer D et al. (1976) Colchicine in familial mediterranean fever. N Engl J Med 294: 170–171
Arzneimittelkommission der Deutschen Ärzteschaft (1979) d-Nor-Pseudoephedrin-haltige Appetit- zügler. Dtsch Ärztebl 76: 2541
Barton CH, Sterlin ML, Vaziri ND (1980) Rhabdomyolysis and acute renal failure associated with phencyclidine intoxication. Arch Intern Med 140: 568–569
Bennett WM. Hazards of the appetite suppressant phenylpropanolamine. Lancet 2: 42–43
Cogen FC, Rigg G, Simmons JL, Domino EF (1978) Phencyclidine-associated acute rhabdomyolysis. Ann Intern Med 88: 210–212
Deocampo PD (1979) Convulsive seizure due to phenylpropanolamine. J Med Soc NJ 76: 591–592
Dietz AJ (1981) Amphetamine-like reaction to phenylpro-panolamine. JAMA 245: 601–602
Ginsberg MD, Hertzmann M, Schmidt-Nowara W (1970) Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke. Ann Intern Med 73: 81–85
Halbach H (1981) Amphetamine Dtsch Arztebl 78: 2398–2404
Kaiser H, Spaar U, Sold G, Wolfrum DI, Kreuzer H (1979) Radioimmunologische Bestimmung von Human-Myoglobin in der Diagnostik des akuten Myokardinfarkts. Klin Wochenschr 57: 225–235
Kendrick WC, Hull AR, Knochel JP (1977) Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med 86: 381–387
Mallach HJ, Pedal I, Lächler H (1980) Das Antiadipositum X 112 in der Drogenszene. Med Welt 31: 220–223
Palmucci L, Bertolotto A, Schiffer D (1978) Acute muscle necrosis after chronic overdosage of phenformin and fenfluramine. Muscle and Nerve 1: 245–247
Penn AS, Rowland LP, Fraser DW (1972) Drugs, coma and myoglobinuria. Arch Neurol 26: 336–342
Penn AS (1979) Myoglobin and myoglobinuria. In Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. North Holland Publ. Co., Amsterdam New York, pp 259–285
Renfordt E, Wirtz W (1980) Mißbrauch von d-norpseudoephedrinhaltigen Appetitzüglern. Nervenarzt 51: 691–693
Rieger G (1981) Paranoid-halluzinatorische Psychosen nach Einnahme von D-Nor-pseudoephedrinhaltigen Appetitzüglern. Nervenarzt 52: 423–425
Rumpf KW, Kaiser H, Mattaei D, Prange H, Goebel HH, Henning HV, Scheler F (1979) Akutes Nierenversagen bei Alkoholmyopathie. Dtsch Med Wochenschr 104: 736–742
Rumpf KW, Kaiser H, Gröne HJ, Trapp VE, Meinck HM, Goebel HH, Kunze E, Kreuzer H, Scheler F (1981) Myoglobinurisches Nierenversagen bei hyperosmolarem diabetischem Koma. Dtsch Med Wochenschr 106: 708–711
Rumpf KW, Kaiser H, Schulze F, Koop H, Trapp VE (1981) Myoglobinurie bei Malabsorption nach Dünndarmresektion. Med Klin 76: 563–565
Simpson DL, Rumack BH (1981) Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology. Arch Intern Med 141: 1507–1509
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Fuchs, C. et al. (1982). Nephrologie. In: Schlegel, B. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 88. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-47093-6_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-47093-6_20
Publisher Name: J.F. Bergmann-Verlag, Munich
Print ISBN: 978-3-8070-0332-0
Online ISBN: 978-3-642-47093-6
eBook Packages: Springer Book Archive